pms-flutamide tablet
pharmascience inc - flutamide - tablet - 250mg - flutamide 250mg - antineoplastic agents
flutamide- flutamide capsule
actavis pharma, inc. - flutamide (unii: 76w6j0943e) (flutamide - unii:76w6j0943e) - flutamide 125 mg - flutamide capsules are indicated for use in combination with lhrh-agonists for the management of locally confined stage b2 -c and stage d2 metastatic carcinoma of the prostate. treatment with flutamide capsules and the goserelin acetate implant should start 8 weeks prior to initiating radiation therapy and continue during radiation therapy. to achieve benefit from treatment, flutamide capsules should be initiated with the lhrh-agonist and continued until progression. flutamide capsules are contraindicated in patients who are hypersensitive to flutamide or any component of this preparation. flutamide capsules are contraindicated in patients with severe hepatic impairment (baseline hepatic enzymes should be evaluated prior to treatment).
teva-flutamide tablet
teva canada limited - flutamide - tablet - 250mg - flutamide 250mg - antineoplastic agents
flutamide 250mg tablets
sovereign medical ltd - flutamide - oral tablet - 250mg
flutamide 250mg tablets
a a h pharmaceuticals ltd - flutamide - oral tablet - 250mg
flutamide 250mg tablets
actavis uk ltd - flutamide - oral tablet - 250mg
flutamide 250mg tablets
viatris uk healthcare ltd - flutamide - oral tablet - 250mg
flutamide 250mg tablets
teva uk ltd - flutamide - oral tablet - 250mg
flutamide 250mg tablets
kent pharma (uk) ltd - flutamide - oral tablet - 250mg
flutamide 250mg tablets
alliance healthcare (distribution) ltd - flutamide - oral tablet - 250mg